Haojie Li

6.5k citations
137 papers · 3.8k indexed · 1 hit paper · h-index 27

Haojie Li

117 papers receiving 3.7k citations

Hit Papers

Pembrolizumab monotherapy for the treatment of high-risk ...3292021202620222024100200300

Peers

Haojie Li
Comparison fields: 5 of 132
  • Cancer Research 675
  • Nutrition and Dietetics 612
  • Pulmonary and Respiratory Medicine 1.1k
  • Oncology 912
  • Pathology and Forensic Medicine 410
Replace Jin‐Hu Fan with:
Jin‐Hu Fan China
Seiichiro Yamamoto Japan
Christian Datz Austria
Youjin Je South Korea
Janet L. Stanford United States
Kimmie Ng United States
D. Amadori Italy
Sumio Kawata Japan
Peter van der Meer Netherlands
Orit Kaidar‐Person Israel
Haojie Li relative to Jin‐Hu Fan China Jin‐Hu Fan's profile →
Citations per field
00.5×
Jin‐Hu Fan · 1×
Citations per year

Countries citing papers authored by Haojie Li

Since Specialization
Citations

This map shows the geographic impact of Haojie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojie Li more than expected).

Fields of papers citing papers by Haojie Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haojie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojie Li. The network helps show where Haojie Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Haojie Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haojie Li Line = papers co-authored together Haojie Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20241
4 20246
5 20240
6 20241
7 20240
8 20233
9 20233
10 20220
11 202214
12 202221
13 202115
14 20213
15 20212
16 202016
17 202023
18 20191
19 201058
20 2007225

About Haojie Li

Haojie Li is a scholar working on Gastroenterology, Oncology and Surgery, having authored 137 papers that have together received 3.8k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (29 papers), Cancer Immunotherapy and Biomarkers (17 papers), Gastric Cancer Management and Outcomes (13 papers), Urinary and Genital Oncology Studies (10 papers), Atrial Fibrillation Management and Outcomes (9 papers), Cardiac Arrhythmias and Treatments (9 papers), Cardiac Structural Anomalies and Repair (8 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). The work is most often cited by research in Cancer Research (675 citations), Nutrition and Dietetics (612 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Haojie Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Meir J. Stampfer, Jing Ma, J. Michael Gaziano, Lorelei A. Mucci, Edward L. Giovannucci, Tobias Kurth, Weiliang Qiu, Reynaldo Martorell, Aryeh D. Stein and Huiman X. Barnhart. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026